Zura Bio Limited Class A Ordinary Shares (ZURA)

Official site

HEALTHCARE • BIOTECHNOLOGY • NASDAQ

$4.28

-0.13 (-2.95%)

Market Cap: $422.61M

Last updated: Oct 16, 2026 at 1:55 PM ET

Earnings

Performance (10Y)

Beat Rate

38%(5/13)

Avg Surprise

-48.61%

Upcoming Estimates

Period ending Sep 30, 2026

EPS Consensus$-0.20

Range$-0.22 - $-0.18

4 analysts

EPS RevisionsNo revisions (7d)

30d

EPS Estimate DriftChange to current

90d ago$-0.18-8.1%

60d ago$-0.18-11.1%

30d ago$-0.20+1.6%

7d ago$-0.20+1.6%

Current$-0.20

Revenue Consensus

Range$0 - $0

6 analysts

Period ending Dec 31, 2026

EPS Consensus$-0.20

Range$-0.30 - $-0.05

4 analysts

Revenue Consensus

Range$0 - $0

7 analysts

Period	Reported	Est.	Range	Surprise	B/M	Analysts	Revisions	YoY
Dec 31, 2026Dec 26EST	-	$-0.20	$-0.30 - $-0.05	-	-	4	-	-
Sep 30, 2026Sep 26EST	-	$-0.20	$-0.22 - $-0.18	-	-	4	0 1 30d	-
Jun 30, 2026Jun 26 Reported Aug 11, 2026Reported Aug 11	$-0.21	$-0.20	$-0.20 - $-0.20	-5.00%	Miss	3	No revisions (30d)	-23.5%
Mar 31, 2026Mar 26 Reported May 7, 2026Reported May 7	$-0.22	$-0.18	$-0.18 - $-0.18	-22.22%	Miss	1	No revisions (30d)	-15.8%
Dec 31, 2025Dec 25 Reported Mar 19, 2026Reported Mar 19	$-0.49	$-0.15	$-0.15 - $-0.15	-226.67%	Miss	1	No revisions (30d)	-390.0%
Sep 30, 2025Sep 25 Reported Nov 13, 2025Reported Nov 13	$-0.21	$-0.18	$-0.21 - $-0.15	-16.67%	Miss	7	2 1 30d	+19.2%
Jun 30, 2025Jun 25 Reported Aug 14, 2025Reported Aug 14	$-0.17	$-0.18	$-0.18 - $-0.18	+5.56%	Beat	0	No revisions (30d)	+0.0%
Mar 31, 2025Mar 25 Reported May 8, 2025Reported May 8	$-0.19	$-0.16	$-0.16 - $-0.16	-18.75%	Miss	0	No revisions (30d)	-850.0%
Dec 31, 2024Dec 24 Reported Mar 25, 2025Reported Mar 25	$-0.10	N/A	-	+58.33%	Beat	7	2 1 30d	+47.4%
Sep 30, 2024Sep 24 Reported Nov 7, 2024Reported Nov 7	$-0.26	$-0.13	$-0.14 - $-0.10	-100.00%	Miss	6	No revisions (30d)	-44.4%
Jun 30, 2024Jun 24 Reported Aug 13, 2024Reported Aug 13	$-0.17	$-0.15	$-0.19 - $-0.11	-13.33%	Miss	6	No revisions (30d)	+87.0%
Mar 31, 2024Mar 24 Reported May 9, 2024Reported May 9	$-0.02	N/A	-	+91.67%	Beat	4	No revisions (30d)	+99.3%
Dec 31, 2023Dec 23 Reported Mar 26, 2024Reported Mar 26	$-0.19	$-0.23	$-0.27 - $-0.19	+17.39%	Beat	5	No revisions (30d)	-575.0%
Sep 30, 2023Sep 23 Reported Nov 13, 2023Reported Nov 13	$-0.18	$-0.23	$-0.30 - $-0.20	+21.74%	Beat	5	No revisions (30d)	-700.0%
Jun 30, 2023Jun 23 Reported Aug 14, 2023Reported Aug 14	$-1.31	$-0.25	-	-424.00%	Miss	-	-	-1107.7%
Mar 31, 2023Mar 23 Reported May 12, 2023Reported May 12	$-2.76	N/A	-	N/A	Beat	-	-	-5615.4%
Dec 31, 2022Dec 22 Reported Mar 30, 2023Reported Mar 30	$0.04	$0.00	-	N/A	Beat	-	-	-15.6%
Sep 30, 2022Sep 22 Reported Nov 14, 2022Reported Nov 14	$0.03	N/A	-	N/A	Beat	-	-	-91.4%
Jun 30, 2022Jun 22 Reported Aug 12, 2022Reported Aug 12	$0.13	N/A	-	N/A	Beat	-	-	-
Mar 31, 2022Mar 22 Reported Jun 29, 2022Reported Jun 29	$0.05	N/A	-	N/A	Beat	-	-	-
Dec 31, 2021Dec 21 Reported Mar 29, 2022Reported Mar 29	$0.05	N/A	-	N/A	Beat	-	-	-
Sep 30, 2021Sep 21 Reported Dec 29, 2021Reported Dec 29	$0.35	N/A	-	N/A	Beat	-	-	-
Jun 30, 2021Jun 21 Reported Sep 28, 2021Reported Sep 28	$0.00	$0.00	-	N/A	Beat	-	-	-

Key Metrics

Valuation
P/E Ratio	-3.79	EV/EBITDA	N/A
Price/FCF	-14.34x	FCF Yield	-6.97%
Profitability
Profit Margin	0.00%	Operating Margin	0.00%
ROE	-51.00%	ROIC	N/A
Financial Health
Debt/Equity	0.00x	Interest Coverage	N/A
Current Ratio	12.90x	Quick Ratio	12.90x
Trading Statistics
Beta	0.01	Avg Volume	3.41M
52-Week High	$7.44	52-Week Low	$3.15

Technical Indicators Dashboard

Moving Averages

SMA 10$4.12

SMA 20$4.18

SMA 50$5.07

SMA 200$5.31

EMA 10$4.20

EMA 20$4.33

EMA 50$4.74

EMA 200$4.77

MACD

Line: -0.23Signal: -0.31Hist: 0.08

ADX

ADX: 26.5+DI: 23.6-DI: 15.5

Aroon & PSAR

Aroon UpN/A

Aroon Down72.0

PSAR$4.76

Bollinger Bands

Upper Band$4.54

Lower Band$3.82

%B Position1730%(Upper)

Band Width0.64

RSI (14-Day)

Neutral

44.7

Momentum Oscillators

Stoch %K50.7

Stoch %D41.2

Williams %R-52.1

ROC (10d)3.4%

Momentum0.14

CCI (20d)52.7

MFI (14d)72.6

Volatility Measures

ATR (14d)$0.36(8.5%)

StdDev (20d)0.18

Hist Vol50.0%(High)

Volume Flow

VWAP$4.31

OBV102.7M

AD Line8.1M

CMF (20d)-0.118

Volume Metrics

Avg Vol (20d)3.6M

Vol Ratio1.4x

VWMA (20d)$4.21

Pivot Points

R3$5.07

R2$4.84

R1$4.63

Pivot Point$4.40

S1$4.18

S2$3.95

S3$3.74

Advanced Oscillators

TSI-25.67

Ultimate Osc42.7

KST-207.64

Financial Data

Quarter	Jun 2026	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024	Sep 2024	Jun 2024	Mar 2024	Dec 2023	Sep 2023
Total Revenue	$0	$0	$0	$0	$0	$0	$2,000	$0	$0	$0	$0	$0
Cost of Revenue	$0	$0	$15,000	$0	$0	$0	$5,000	$0	$0	$0	N/A	$0
Gross Profit	$0	$0	$-15,000	$0	$0	$0	$-5,000	$0	$0	$0	N/A	$0

Operating Expenses	$29.32M	$25.50M	$18.41M	$19.52M	$18.06M	$19.25M	$15.73M	$19.32M	$11.76M	$8.38M	$10.83M	$10.19M
R&D	$20.71M	$14.75M	$10.96M	$11.95M	$8.70M	$10.47M	$9.24M	$6.03M	$5.54M	$3.59M	$6.92M	$3.96M
SG&A	$8.62M	$10.75M	$7.46M	$7.57M	$9.36M	$8.78M	$6.49M	$13.29M	$6.22M	$4.79M	$3.91M	$6.22M
Operating Income	$-29,321,000	$-25,499,000	$-18,411,000	$-19,519,000	$-18,062,000	$-19,254,000	$-15,732,000	$-19,319,000	$-11,759,000	$-8,379,000	$-10,827,000	$-10,187,000

Interest Income	$1.92M	$1.32M	$1.28M	$1.53M	$1.72M	$1.82M	$2.13M	$2.46M	$2.20M	$1.22M	$1.37M	$1.80M
Interest Expense	$0	$0	$0	$0	$0	$0	$0	$1.38M	$0	$0	$0	$0
Income Before Tax	$-26,385,000	$-24,223,000	$-17,175,000	$-18,040,000	$-15,993,000	$-17,442,000	$-13,625,000	$-20,702,000	$-10,329,000	$-7,747,000	$-8,473,000	$-8,270,000
Income Tax Expense	$-81,000	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0

Net Income	$-26,304,000	$-24,223,000	$-17,175,000	$-18,040,000	$-15,993,000	$-17,442,000	$-13,625,000	$-20,702,000	$-10,329,000	$-7,747,000	$-8,473,000	$-8,270,000

EBITDA	$-28,320,968	$-25,483,000	$-18,441,000	$-19,552,000	$-17,718,980	$-19,245,000	$-15,744,000	$-23,160,000	$-12,526,000	$-8,962,000	$-9,850,000	$-10,068,000
EBIT	$-28,305,000	$-25,499,000	$-18,456,000	$-19,566,000	$-17,710,000	$-19,254,000	$-15,749,000	$-23,163,000	$-12,527,000	$-8,962,000	$-9,850,000	$-10,068,000

* Some calculated fields are derived from available data when not provided by source

Related GNG Research

No research available

Be the first to write about ZURA

News

Zura Bio (NASDAQ: ZURA) director plans 50,000-share sale after prior trades

A director of Zura Bio (NASDAQ: ZURA), Someit Sidhu, intends to sell 50,000 common shares valued at $287,712.50, originating from a stock option exercise, on August 18...

Stock Titan•Aug 18, 2026 8:40 PM ET8/18/26•Somewhat-Bearish

Zura Bio (NASDAQ: ZURA) affiliate plans stock sale via option exercise

An affiliate of Zura Bio (NASDAQ: ZURA), Someit Sidhu, has filed a Form 144 indicating a planned sale of 27,000 shares of ZURA common stock on or about August 17...

Stock Titan•Aug 17, 2026 8:40 PM ET8/17/26•Neutral

Zura Bio Ltd SEC Filing (Aug 13, 2026)

This article reports on an SEC Form 144 filing by Zura Bio Ltd on August 13, 2026. The filing indicates a proposed sale of 51,000 shares of common stock, acquired through a stock option exercise...

Stock Titan•Aug 14, 2026 2:12 PM ET8/14/26•Neutral

Zura Bio Completes Enrollment in 247-Participant Hidradenitis Study

Zura Bio announced the completion of enrollment for its Phase 2 TibuSHIELD study in hidradenitis suppurativa (HS) with 247 participants and the TibuSURE study in systemic sclerosis (SSc) with 91 participants...

Stock Titan•Aug 11, 2026 7:17 AM ET8/11/26•Bullish

ZURA Valuation and Fair Value

P/E: -3.8x
P/FCF: -14.3x
P/B: 2.8x

See GNG's fair value

ZURA Profitability: Margins, ROIC and FCF

Operating margin: 0.0%
Net margin: 0.0%
ROE: -51.0%
FCF yield: -7.0%

ZURA Competitors

Company	Ticker
Ovid Therapeutics Inc	OVID
Community Health Systems Inc	CYH
Cross Country Healthcare Inc	CCRN
Prenetics Global Ltd	PRE
Prothena Corporation plc	PRTA
DiaMedica Therapeutics Inc	DMAC
Neuropace Inc	NPCE
Tectonic Therapeutic, Inc.	TECX

Sector: Healthcare

ZURA Analyst Ratings

Consensus: Buy
Analysts: 7
Strong Buy: 1
Buy: 6
Hold: 0
Sell: 0
Strong Sell: 0

ZURA Bull Case vs Bear Case

Bull case

100.0% of ZURA's analyst ratings are Buy or Strong Buy.

Bear case

ZURA beat EPS estimates in 25.0% of its last 8 reported quarters.

ZURA Earnings: Beat Rate and Next Report

Beat rate: 2 of 8 quarters (25.0%)
Average surprise: -40.7%
EPS estimate (fiscal period ending Sep 30, 2026): $-0.20
Estimate revisions (30 days, fiscal period ending Sep 30, 2026): 0 up, 1 down

Frequently Asked Questions About ZURA

Does ZURA pay dividends?

Zura Bio Limited Class A Ordinary Shares (ZURA) does not currently pay a regular dividend.

What is ZURA's market cap?

Zura Bio Limited Class A Ordinary Shares (ZURA) has a market capitalization of $422.61M with a current stock price of $4.28.

Get full access to GNG Research

Create a free account to access portfolio tracking, advanced tools, and more.

Create Free Account Log In